1. Where are we in the COVID-19 vaccine race?  The Edge Markets MY
  2. Pfizer to file for emergency use of Covid-19 vaccine after US election  Free Malaysia Today
  3. Korea to expect COVID-19 vaccine soon / NK denounces Japan with 'Statue of Peace' / Dokdo concert  KOREA NOW
  4. US hoping for two Covid-19 vaccines by end of November  Malay Mail
  5. Tough on Anti-Vaxx Nonsense, Tough on the Causes of Anti-Vaxx Nonsense  Jacobin magazine
  6. View Full coverage on Google News

WASHINGTON, Oct 17 — Two American companies expect to apply for emergency approval for their Covid-19 vaccines by late November, welcome news as the US crossed eight million confirmed cases amid a third surge of its coronavirus epidemic. Pfizer said yesterday it hopes to move ahead with its...WASHINGTON, Oct 17 — Two American companies expect to apply for emergency approval for their Covid-19 vaccines by late November, welcome news as the US crossed eight million confirmed cases amid a third surge of its coronavirus epidemic. Pfizer said yesterday it hopes to move ahead with its...

US hoping for two Covid-19 vaccines by end of November | World | Malay Mail

It’s Not Just Parties: Small Household Gatherings Are Leading To More COVID-19 Cases - NowThis

The 48-page plan provides the framework on who will receive the vaccination first.The 48-page plan provides the framework on who will receive the vaccination first.

Kentucky unveils draft plan for COVID-19 vaccine distribution. Here’s what you need to know

Fauci offered guidance about when the COVID-19 vaccine may be truly availableFauci offered guidance about when the COVID-19 vaccine may be truly available

When will the COVID-19 vaccine be available? - Deseret News

(Reuters) - U.S. President Donald Trump and the head of the Centers for Disease Control and Prevention (CDC) have disagreed about when a COVID-19 vaccine would become widely available. Trump has said enough vaccine would be available for every American by April, while the CDC director said vaccines were likely to reach the general public around mid-2021, an assessment more in line with most experts.(Reuters) - U.S. President Donald Trump and the head of the Centers for Disease Control and Prevention (CDC) have disagreed about when a COVID-19 vaccine would become widely available. Trump has said enough vaccine would be available for every American by April, while the CDC director said vaccines were likely to reach the general public around mid-2021, an assessment more in line with most experts.

Explainer: When will COVID-19 vaccines be generally available in the United States? | The Star

In the battle of the coronavirus vaccines, experience is key.In the battle of the coronavirus vaccines, experience is key.

Better Coronavirus Stock: AstraZeneca or Moderna? | The Motley Fool

Perhaps months away from the first COVID-19 vaccines, their effectiveness may be threatened by growing anti-vaccination sentiment in the Global North. The Left should brook no vaccine skepticism in its ranks, but we should also work to prevent the conditions that give rise to such irrationality in the first place.

Tough on Anti-Vaxx Nonsense, Tough on the Causes of Anti-Vaxx Nonsense

The CDC put out a central playbook for how to distribute the shots. But how states will address these guidelines is anything but uniform.The CDC put out a central playbook for how to distribute the shots. But how states will address these guidelines is anything but uniform.

In the US, 50 States Could Mean 50 Vaccine Rollout Strategies | WIRED

Trump, Biden square off in dueling town halls, U.S. Covid-19 cases reach a third peak, date set for committee vote on Barrett nomination, and other news to start your day. Trump, Biden square off in dueling town halls, U.S. Covid-19 cases reach a third peak, date set for committee vote on Barrett nomination, and other news to start your day.

Pfizer and BioNTech Vaccine Could Be Ready By the End of November. We’re All Winners. | Barron's

Pfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes wellPfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well

WASHINGTON" The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.WASHINGTON" The US pharmaceutical giant Pfizer expects to file for emergency use authorisation for its Covid-19 vaccine in late November, around two weeks after the Nov 3 US presidential election, it said on Friday.

Pfizer to seek vaccine approval in November

The final results for multiple coronavirus vaccine candidates might be ready this winter, at which point the successful candidates could be available for emergency immunization campaigns.The final results for multiple coronavirus vaccine candidates might be ready this winter, at which point the successful candidates could be available for emergency immunization campaigns. The World…

Healthy young people might not get a coronavirus vaccine until 2022 – BGR

The head of the UK Vaccine Taskforce says it would not mean that life would get back to normal straight away.The head of the UK Vaccine Taskforce says it would not mean that life would get back to normal straight away.

sign-in

A COVID-19 vaccine could arrive before the end of 2020, based on a timeline Pfizer's CEO laid out. In an open letter posted to Pfizer's website, CEO Albert Bourla wrote, "Assuming positive data, Pfizer will apply for emergency authorization use in the U. S. soon after the safety milestone is achieved in the third week of November. " COVID-19: Find the latest news on the outbreak in West Michigan by visiting the News Channel 3 coronavirus page.A COVID-19 vaccine could arrive before the end of 2020, based on a timeline Pfizer's CEO laid out. In an open letter posted to Pfizer's website, CEO Albert Bourla wrote, "Assuming positive data, Pfizer will apply for emergency authorization use in the U. S. soon after the safety milestone is achieved in the third week of November. " COVID-19: Find the latest news on the outbreak in West Michigan by visiting the News Channel 3 coronavirus page.

Pfizer could seek November vaccine authorization | WWMT

Pfizer could seek November vaccine authorization

According to the recent World Bank report, an estimated 1 billion students in developing nations may be out of school. CoronavirusA World Bank report says about 1 billion students in developing countries may be out of school due to the looming second wave of COVID-19.

1 billion students in developing nations may be out of school due to second wave of COVID-19 - World Bank | Nairametrics

“These pauses are an example of the system that’s in place working well.”“These pauses are an example of the system that’s in place working well.”

"The absence of national leadership on COVID-19 is unprecedented and dangerous," a letter states."The absence of national leadership on COVID-19 is unprecedented and dangerous," a letter states.

Over 1,000 current and ex-CDC officers decry the "politicization" of the agency - Axios

On Friday, Pfizer announced that it may attempt to file for emergency use authorization with the FDA by late November. This comes as the WHO says Remdesivir has ‘little or no effect’ in preventing deaths in patients with coronavirus. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.On Friday, Pfizer announced that it may attempt to file for emergency use authorization with the FDA by late November. This comes as the WHO says Remdesivir has ‘little or no effect’ in preventing deaths in patients with coronavirus. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.

Coronavirus Latest: Friday, October 16

Some states, including Wisconsin, are experiencing a strain on hospitals, as Pfizer announced today that it won't likely be able to apply for emergency use for its vaccine until a few weeks after the election.Some states, including Wisconsin, are experiencing a strain on hospitals, as Pfizer announced today that it won't likely be able to apply for emergency use for its vaccine until a few weeks after the election.

US surpasses 8 million COVID-19 cases | CIDRAP

US pharmaceutical giant Pfizer says it will likely apply for emergency authorization of a coronavirus vaccine in the United States as early as late November.US pharmaceutical giant Pfizer says it will likely apply for emergency authorization of a coronavirus vaccine in the United States as early as late November.

Pfizer may seek vaccine approval in late Nov. | NHK WORLD-JAPAN News

Currently, only doctors, pharmacists and some nurses are legally allowed to administer vaccines in the UK. But new laws passed today give the ability to more health workers, including physios.Currently, only doctors, pharmacists and some nurses are legally allowed to administer vaccines in the UK. But new laws passed today give the ability to more health workers, including physios.

Physios and paramedics will be trained to deliver flu and Covid-19 jabs | Daily Mail Online

YouTube is introducing new policy updates to combat the spread of COVID-19 vaccine misinformation shared on its platform, according to CNBC.

YouTube expands medical misinformation policy

British biotech firm hVIVO is in talks to create and provide strains of the Covid-19 virus which can be used for human challenge trials. British biotech firm hVIVO is in talks to create and provide strains of the Covid-19 virus which can be used for human challenge trials.

U.K. Government Reportedly In Advanced Talks To Initiate Human Challenge Vaccine Trials That Would See Volunteers Infected With Covid-19

Pfizer (PFE) stock is on the higher after the company announced it could submit an Emergency Use Authorization application by as soon as the end of November

Blue-Chip Drugmaker Moves Higher on Vaccine Announcement

LAS VEGAS (FOX5) -- Nevada's Department of Health and Human Services, Division of Public and Behavioral Health submitted a vaccine program to the Centers for Disease Control and Prevention.LAS VEGAS (FOX5) -- Nevada's Department of Health and Human Services, Division of Public and Behavioral Health submitted a vaccine program to the Centers for Disease Control and Prevention.

Nevada submits COVID-19 vaccine program to CDC | Coronavirus | fox5vegas.com

According to reports, NHS England is in dialogue with the BMA and other groups over rolling out a vaccine by the end of the calendar year According to reports, NHS England is in dialogue with the BMA and other groups over rolling out a vaccine by the end of the calendar year

NHS 'in talks' over coronavirus vaccine programme by as soon as December - Birmingham Live

403 Missing Auth Token

The documents were submitted to the Center of Disease Control and Prevention for review and approval.The documents were submitted to the Center of Disease Control and Prevention for review and approval.

Iowa health officials submit plan to CDC on distributing vaccine when available

Vaccine developers must provide two months of safety data on half of the trial participants following the final dose of the vaccine.Vaccine developers must provide two months of safety data on half of the trial participants following the final dose of the vaccine.

"I think it's more likely that it'll be in early next year," said Kate Bingham."I think it's more likely that it'll be in early next year," said Kate Bingham.

There's a slim chance a COVID-19 vaccine may be ready by Christmas, says chair of U.K. Vaccine Taskforce - CBS News

GENEVA/ZURICH • The World Health Organisation (WHO) on Wednesday said healthy young people might have to wait until 2022 to be vaccinated against Covid-19, as it warned against complacency in the disease death rate.. Read more at straitstimes.com.Europe News -GENEVA/ZURICH • The World Health Organisation (WHO) on Wednesday said healthy young people might have to wait until 2022 to be vaccinated against Covid-19, as it warned against

Youth may need to wait till 2022 for vaccine: WHO, Europe News & Top Stories - The Straits Times

investors got excited over the news that revealed Pfizer Inc could have a COVID-19 vaccine available for the US economy by the end of 2020.Pfizer Inc could have a COVID-19 vaccine available in the world's largest economy by the end of 2020.

Pfizer's COVID-19 vaccine boosts U.S Stocks | Nairametrics

The USA is the worst-hit country in the world with more than eight million Covid-19 cases and 218,000 deathsThe USA is the worst-hit country in the world with more than eight million Covid-19 cases and 218,000 deaths

US hoping for 2 Covid-19 vaccines by end of November | Dhaka Tribune

An influential COVID-19 model calls out North Dakota's death rate and says masks can save 74,000 U.S. lives. Latest coronavirus news.An influential COVID-19 model calls out North Dakota's death rate and says masks can save 74,000 U.S. lives. Latest coronavirus news.

COVID news: Winter surge; no vaccine before election; Europe cases

While countries around the world have been making desperate efforts to get Covid-19 vaccines, Bangladesh's initiatives to get the vaccine, unfortunately, is not that visible. Our government has refused to co-fund the trials of a Chinese Covid-19 vaccine at a time when a number of countries have already made investments to get vaccines from companies that were conductingWhile countries around the world have been making desperate efforts to get Covid-19 vaccines, Bangladesh’s initiatives to get the vaccine,

Govt needs to make a decision on getting Covid-19 vaccines | The Daily Star

The move by Pfizer continues the company's push to publicly distance itself from the presidential race.

Pfizer won't seek coronavirus vaccine authorization until after election - POLITICO

Pfizer said that it would likely seek emergency approval for a COVID-19 vaccine in late November, citing recent federal guidance that toughened approval…Pfizer Announcement All But Ends Worries About Pre-Election Day Vaccine Campaign Prop

Pfizer Announcement All But Ends Worries About Pre-Election Day Vaccine Campaign Prop | Talking Points Memo

It's important to remember that it isn't all doom and gloom - and there are reasons to be optimisticIt's important to remember that it isn't all doom and gloom - and there are reasons to be optimistic

Covid-19 Ireland good news: Christmas hope and vaccine timeline emerges - Irish Mirror Online